Breast Neoplasms  >>  epirubicin  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT01199432: Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer

Completed
4
501
RoW
5-FU（intravenous infusion）+epirubicin+cyclophosphamide, CEFci, 5-FU（intravenous bolus）+epirubicin+cyclophosphamide, CEF, epirubicin+cyclophosphamide, EC
Tao OUYANG
Breast Cancer
07/14
12/14
MINT, NCT01501487: I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I

Completed
4
226
US
TAC chemotherapy, TC chemotherapy, Dose Dense AC or FEC100 followed by paclitaxel or docetaxel chemotherapy, TCH chemotherapy, T + trastuzumab followed by CEF + trastuzumab, Dose dense AC followed by T + trastuzumab, Dose dense AC followed by T + trastuzumab + pertuzumab, PTH followed by dose dense AC of FEC
Agendia, University of South Florida, University of Miami, Morton Plant Mease Health Care, AdventHealth, Plano Cancer Center, Ohio State University Comprehensive Cancer Center, University of Oklahoma, University of South Alabama
Breast Cancer
02/16
06/17
OTT15-04, NCT02688803: Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)

Completed
4
2
Canada
Dose dense AC-P, doxorubicin, cyclophosphamide, paclitaxel, Dose dense AC, FEC-D, 5-FU, docetaxel
Ottawa Hospital Research Institute
Breast Cancer
10/17
10/17
NCT02627248: Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Recruiting
4
200
RoW
Huaier Granule, Epirubicin, Docetaxel, Cyclophosphamide
Shandong University
Breast Cancer
10/25
10/25

Download Options